Figure 1
Figure 1. Impaired calcium influx in Orai1R93W platelets. (A) Schematic diagram showing the targeting strategy for Orai1R93W knockin mice. A detailed description of the targeting strategy is given in Document S1. (B) Calcium flux in Orai1R93W platelets. Fluo-3–labeled WT (gray line) or Orai1R93W platelets (black line) were stimulated with the indicated agonists in the presence of 0.5 mM CaCl2. In the thapsigargin (TG) experiment, cells were first treated with TG in the absence of extracellular Ca2+ followed by addition of 0.5 mM CaCl2 (arrows). Mean fluorescence intensity (MFI) was recorded over time on a FACSCalibur. Results are representative of 5 independent experiments. Cvx, convulxin; PAR4p, PAR4 receptor activating peptide.

Impaired calcium influx in Orai1R93W platelets. (A) Schematic diagram showing the targeting strategy for Orai1R93W knockin mice. A detailed description of the targeting strategy is given in Document S1. (B) Calcium flux in Orai1R93W platelets. Fluo-3–labeled WT (gray line) or Orai1R93W platelets (black line) were stimulated with the indicated agonists in the presence of 0.5 mM CaCl2. In the thapsigargin (TG) experiment, cells were first treated with TG in the absence of extracellular Ca2+ followed by addition of 0.5 mM CaCl2 (arrows). Mean fluorescence intensity (MFI) was recorded over time on a FACSCalibur. Results are representative of 5 independent experiments. Cvx, convulxin; PAR4p, PAR4 receptor activating peptide.

Close Modal

or Create an Account

Close Modal
Close Modal